Shots:
Trial assessed eneboparatide (ENB; QD, SC) vs PBO for 24wks. in 202 adults with HypoPT on active vitamin D & oral Ca supplements; Pts then continued ENB (ENB/ENB) or switched from PBO to ENB (PBO/ENB) in a 28wk. OLE
Trial met its composite 1EP, with 31.1% pts achieving normalized albumin-adjusted sCa levels & independence…
